Recovery ⏱ Half-life: Short. Preclinical

Bronchogen

Bronchogen (AED Peptide)

Updated March 15, 2026

Evidence at a Glance

Regulatory statusPreclinical
Khavinson short-peptide bioregulator (Ala-Glu-Asp-Leu); Russian-origin data only, not FDA-approved.
Human evidenceNone
Animal evidenceLimited

Bronchogen is a Russian-developed tetrapeptide bioregulator supported almost entirely by Khavinson-group animal and cell studies, with no peer-reviewed controlled human trials.

What the research does not support

  • It is not FDA-approved and is not a treatment for COPD, asthma, or any respiratory disease.
  • No randomized controlled human trials establish that it improves lung function.
  • Claims of anti-aging or gene-regulating respiratory benefits rest on limited single-group Russian data, not independent replication.
Half-Life
Short.
Mol. Weight
~320 g/mol

What is Bronchogen?

Bronchogen is a synthetic tripeptide bioregulator designed to support bronchial and respiratory tissue function.

Research Applications

Respiratory tissue support, bronchial inflammation, and epithelial recovery research.

Dosage Information (Research Use)

10-20 mg/day for 10-30 day courses. Research use only.

Reconstitution & Handling

Standard BAC water or oral capsules.

Half-Life & Pharmacokinetics

Short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK. “Peptide Bioregulators.” Neuro Endocrinol Lett. 2003

How Bronchogen Works

Bronchogen targets bronchial mucosa, modulating gene expression in epithelial cells to support respiratory tissue integrity and inflammatory balance.

Research Findings

Part of the Khavinson peptide bioregulator series. Studied in chronic obstructive respiratory conditions.

Dosage & Administration

10-20 mg/day for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Ala-Glu-Asp
Molecular Weight ~320 g/mol
Half-Life Short.
Available Sizes 5mg
Storage Lyophilized: -20°C.

Key Research References

  • Khavinson VK. "Peptide Bioregulators." Neuro Endocrinol Lett. 2003

Related Peptides

View all →
Vesilute
Recovery
Bladder-targeting peptide bioregulator researched for urinary tract epithelial support and detrusor muscle function.
View Profile →
Linaclotide
Recovery
FDA-approved 14-amino acid peptide for IBS-C and chronic constipation that works by activating guanylate cyclase-C receptors in the…
View Profile →
Vesugen
Recovery
Vascular-targeting tripeptide bioregulator researched for endothelial function and microcirculation support.
View Profile →